Article Details
Retrieved on: 2021-07-21 07:46:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The U.S. government is pausing the distribution of monoclonal antibodies bamlanivimab and etesevimab in high-risk COVID-19 outpatients.
Article found on: combatcovid.hhs.gov
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here